Source-grounded facts extracted from Ocugen, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Sanjay S. Subramanian resigned as Chief Financial Officer at Ocugen, Inc..
“On March 2, 2022, Sanjay S. Subramanian, Chief Financial Officer and Head of Corporate Development of Ocugen, Inc. (the “Company”), tendered his resignation to the Company, effective as of March 18, 2022 (the “Effective Date”), in order to pursue new opportunities.”
Suha Taspolatoglu resigned as Member of the Board of Directors at Ocugen, Inc..
“On December 9, 2021, Suha Taspolatoglu, M.D., a member of the Board of Directors (the “ Board ”) of Ocugen, Inc. (the “ Company ”), notified the Company of his intention to resign from his position as a member of the Board and as a member of the Audit Committee of the Board (the “ Audit Committee ”) effective as of December 10, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.